XML 32 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

Property and Equipment | 12 Months Ended
--- | ---
Dec. 31, 2022
Property, Plant and Equipment [Abstract] |
Property and Equipment | Note 11. Property and Equipment The following table sets forth the components of the Company’s property and equipment at December 31, 2022 and 2021:
Schedule of property and equipment, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | December 31, 2022 |  |  | December 31, 2021 |
|  | Gross Carrying Amount |  |  | Accumulated Depreciation/Amortization |  |  | Net Book Value |  |  | Gross Carrying Amount |  |  | Accumulated Depreciation |  |  | Net Book Value |
Office furniture |  | $ | 14,998 |  |  | $ | 5,912 |  |  | $ | 9,086 |  |  | $ | 14,998 |  |  | $ | 4,000 |  |  | $ | 10,998 |
Vehicles |  |  | 36,432 |  |  |  | 26,110 |  |  |  | 10,322 |  |  |  | 48,248 |  |  |  | 26,306 |  |  |  | 21,942 |
Equipment |  |  | 763,852 |  |  |  | 277,288 |  |  |  | 486,564 |  |  |  | - |  |  |  | - |  |  |  | - |
Property |  |  | 140,000 |  |  |  | - |  |  |  | 140,000 |  |  |  | - |  |  |  | - |  |  |  | - |
Finance lease- Right of use assets |  |  | 3,579,544 |  |  |  | 349,253 |  |  |  | 3,230,291 |  |  |  | - |  |  |  | - |  |  |  | - |
Precious metal extraction machine- 1 ton |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,280,000 |  |  |  | 228,000 |  |  |  | 2,052,000 |
Precious metal extraction machine- 10 ton |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 5,320,000 |  |  |  | 532,000 |  |  |  | 4,788,000 |
Construction in process: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bioreactors |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 1,440,000 |  |  |  | - |  |  |  | 1,440,000 |
Wash Plant Facilities |  |  | 199,800 |  |  |  | - |  |  |  | 199,800 |  |  |  |  |  |  |  |  |  |  |  |  |
Nanosponge/Cavitation device |  |  | 44,603 |  |  |  | - |  |  |  | 44,603 |  |  |  | 22,103 |  |  |  | - |  |  |  | 22,103 |
Remediation Processing Unit 1 |  |  | 4,396,753 |  |  |  | - |  |  |  | 4,396,753 |  |  |  | 6,249,082 |  |  |  | - |  |  |  | 6,249,082 |
Remediation Processing Unit 2 |  |  | 6,285,547 |  |  |  | - |  |  |  | 6,285,547 |  |  |  | 5,201,098 |  |  |  | - |  |  |  | 5,201,098 |
Remediation Processing Unit System A |  |  | 3,893,051 |  |  |  | - |  |  |  | 3,893,051 |  |  |  | 2,561,467 |  |  |  | - |  |  |  | 2,561,467 |
Remediation Processing Unit System B |  |  | 3,845,398 |  |  |  | - |  |  |  | 3,845,398 |  |  |  | 2,345,421 |  |  |  | - |  |  |  | 2,345,421 |
Total fixed assets |  | $ | 23,256,006 |  |  | $ | 677,130 |  |  | $ | 22,578,876 |  |  | $ | 25,482,417 |  |  | $ | 790,306 |  |  | $ | 24,692,111 |
For the year ended December 31, 2021 the Company paid $64,950 with 5,413 shares of Series C-1 Preferred Stock for equipment, which has been valued based on similar cash purchases of the Series C-1 Preferred Stock at approximately $12.00 per share. For the years ended December 31, 2022 and 2021 depreciation expense was $638,073 and $11,561. For the years ended December 31, 2022 and 2021 capitalized interest to equipment from debt financing was none and $1,614,697. Equipment that is currently being manufactured is considered construction in process and is not depreciated until the equipment is placed into service. Equipment that is temporarily not in service is not depreciated until placed into service. The operations surrounding our precious metals extraction services were temporarily suspended until recently, although due to these suspended activities and a shift in 2022 of the Company’s focus to the oil and gas industry, we have realized an impairment loss of $6,269,998 surrounding the extraction machinery for the year ended December 31, 2022. As of December 31, 2022 we continued to pursue a test facility or third party reactor for our nano catalyst technology that facilitates chemical manufacturing, with a focus on the production of ammonia, which includes our bioreactor equipment. The Company received recent quotes for testing or building our own test facilities with new partners for this venture. After taking into consideration this new information, we noted that the newly requested capital expenditure to test and scale the business triggered an impairment loss of assets related to our ammonia synthesis assets, including our bioreactors. The impairment loss related to our bioreactors was $1,440,000 for the year ended December 31, 2022.

X
- References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI https://asc.fasb.org/topic&trid=2155823 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916 + Details
Name: | us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration